Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency

被引:6
|
作者
Fry, Lewis E. [1 ,2 ,3 ]
Peddle, Caroline F. [1 ,2 ]
Stevanovic, Marta [1 ,2 ]
Barnard, Alun R. [1 ,2 ,3 ]
McClements, Michelle E. [1 ,2 ]
MacLaren, Robert E. [1 ,2 ,3 ]
机构
[1] Univ Oxford, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Oxford, England
[2] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
[3] Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England
来源
CRISPR JOURNAL | 2020年 / 3卷 / 04期
关键词
MOUSE MODEL; TRANSCRIPTIONAL INTERFERENCE; THERAPY; MUSCLE; LIVER; EFFICACY; GENOMES; SYSTEM;
D O I
10.1089/crispr.2020.0021
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Adeno-associated virus (AAV) vectors have been widely adopted for delivery of CRISPR-Cas components, especially for therapeutic gene editing. For a single vector system, both the Cas9 and guide RNA (gRNA) are encoded within a single transgene, usually from separate promoters. Careful design of this bi-cistronic construct is required due to the minimal packaging capacity of AAV. We investigated how placement of the U6 promoter expressing the gRNA on the reverse strand to SaCas9 driven by a cytomegalovirus promoter affected gene editing rates compared to placement on the forward strand. We show that orientation in the reverse direction reduces editing rates from an AAV vector due to reduced transcription of both SaCas9 and guide RNA. This effect was observed only following AAV transduction; it was not seen following plasmid transfection. These results have implications for the design of AAV-CRISPR vectors, and suggest that results from optimizing plasmid transgenes may not translate when delivered via AAV.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 50 条
  • [31] CRISPR/CAS9 GENE EDITING TO BLOCK MALARIA TRANSMISSION
    Simoes, Maria
    Dong, Yuemei
    Dimopoulos, George
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 262 - 262
  • [32] CRISPR/Cas9 gene editing for genodermatoses: progress and perspectives
    Naso, Gaetano
    Petrova, Anastasia
    EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (03) : 313 - 326
  • [33] CRISPR/Cas9 gene editing therapies for cystic fibrosis
    Graham, Carina
    Hart, Stephen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (06) : 767 - 780
  • [34] The enhancement of CRISPR/Cas9 gene editing using metformin
    Rollins, Jaedyn L.
    Hall, Raquel M.
    Lemus, Clara J.
    Leisten, Lauren A.
    Johnston, Jennifer M.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2023, 35
  • [35] CRISPR/CAS9 GENE EDITING APPLICATIONS IN CARDIOVASCULAR DISEASE
    Khouzam, J.
    Khouzam, R.
    Tivakaran, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 423 - 424
  • [36] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
    Xu, Sen
    Pham, Thinh
    Neupane, Swatantra
    MARINE LIFE SCIENCE & TECHNOLOGY, 2020, 2 (01) : 1 - 5
  • [37] Therapeutic gene editing in haematological disorders with CRISPR/Cas9
    Jensen, Trine I.
    Axelgaard, Esben
    Bak, Rasmus O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 821 - 835
  • [38] Lipid and polymer mediated CRISPR/Cas9 gene editing
    Gong, Yan
    Tian, Siyu
    Xuan, Yang
    Zhang, Shubiao
    JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (20) : 4369 - 4386
  • [39] Gene editing using CRISPR/Cas9 in neuromuscular disorders
    Gonorazky, H.
    Maani, N.
    Khattak, S.
    Ivakine, Z.
    Cohn, R.
    Dowling, J.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S127 - S127
  • [40] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
    Sen Xu
    Thinh Phu Pham
    Swatantra Neupane
    Marine Life Science & Technology, 2020, 2 : 1 - 5